Compare LOB & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LOB | ATEC |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2014 | 2006 |
| Metric | LOB | ATEC |
|---|---|---|
| Price | $31.91 | $6.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $40.50 | $12.93 |
| AVG Volume (30 Days) | 262.1K | ★ 5.3M |
| Earning Date | 10-21-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.37% | N/A |
| EPS Growth | ★ 31.95 | 15.04 |
| EPS | ★ 1.86 | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $12.75 | $12.80 |
| Revenue Next Year | $13.70 | $13.44 |
| P/E Ratio | $17.59 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.18 | $6.71 |
| 52 Week High | $44.53 | $23.29 |
| Indicator | LOB | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 29.22 | 33.58 |
| Support Level | $31.44 | N/A |
| Resistance Level | $38.49 | $9.84 |
| Average True Range (ATR) | 1.14 | 0.44 |
| MACD | -0.15 | -0.05 |
| Stochastic Oscillator | 0.21 | 3.09 |
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.